Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapies
Abstract
Background Gastric cancer (GC) is confronted with limited options for precision medicine. Human epidermal growth factor receptor 2 (HER2) is the principal druggable target of GC, yet proper biomarkers for response/resistance prediction remain unveiled. Methods From 40 GC patients received HER2‐targeted therapy, a total of 327 peripheral blood plasma specimens was collected including baseline and treatment time points. Circulating tumor DNA...
Paper Details
Title
Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapies
Published Date
Dec 1, 2020
Volume
10
Issue
8
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History